Cargando…
Expression of Immunomodulatory Checkpoint Molecules in Drug-Resistant Neuroblastoma: An Exploratory Study
SIMPLE SUMMARY: Neuroblastoma is a common childhood cancer with poor prognosis. Prior studies suggest that inhibition of molecules called checkpoint proteins, which normally prevent one’s own immune system from attacking itself, has been successfully used for treatment of multiple advanced adult can...
Autores principales: | Skertich, Nicholas J., Chu, Fei, Tarhoni, Imad A. M., Szajek, Stephen, Borgia, Jeffrey A., Madonna, Mary Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833944/ https://www.ncbi.nlm.nih.gov/pubmed/35159017 http://dx.doi.org/10.3390/cancers14030751 |
Ejemplares similares
-
Expression of programmed death ligand 1 in drug-resistant osteosarcoma: An exploratory study()()
por: Skertich, Nicholas J., et al.
Publicado: (2021) -
The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012) -
Biological Insight and Recent Advancement in the Treatment of Neuroblastoma
por: Rivera, Zoriamin, et al.
Publicado: (2023) -
Midkine Mediates Intercellular Crosstalk between Drug-Resistant and Drug-Sensitive Neuroblastoma Cells In Vitro and In Vivo
por: Chu, Fei, et al.
Publicado: (2013) -
GABA is an effective immunomodulatory molecule
por: Jin, Zhe, et al.
Publicado: (2011)